Civetta Therapeutics is a small molecule targeting of beta-propeller domains founded in 2019.
1
Funding Rounds
$53.0m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
The company Civetta Therapeutics has raised a total of $53m in funding over 1 rounds.